Yuki Gosei Kogyo Co., Ltd. (TYO:4531)

Market Cap	7.84B +29.5%
Revenue (ttm)	15.74B -0.8%
Net Income	417.00M -41.1%
EPS	19.30 -41.2%
Shares Out	21.54M
PE Ratio	18.86
Forward PE	n/a
Dividend	10.00 (2.78%)
Ex-Dividend Date	Mar 30, 2026

Volume	17,600
Open	364.00
Previous Close	364.00
Day's Range	363.00 - 367.00
52-Week Range	274.00 - 640.00
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Yuki Gosei Kogyo

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets amino acids, chemical products, and pharmaceuticals in Japan and internationally. It offers food additives, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, active pharmaceutical ingredients, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1947
• Employees: 296
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4531

Financial Performance

In fiscal year 2026, Yuki Gosei Kogyo's revenue was 15.45 billion, an increase of 2.12% compared to the previous year's 15.13 billion. Earnings were 313.00 million, a decrease of -65.07%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 27, 2026

Data Sources Report a data error